Literature DB >> 2076384

Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.

J M Rapola1, T J Pellinen, P Koskinen, L Toivonen, M S Nieminen.   

Abstract

Hemodynamic effects of intravenous and oral pindolol and atenolol were assessed in ten healthy volunteers by left ventricular echocardiography and systolic time intervals. Measurements were made at rest and during hand-grip-induced isometric exercise. Drug doses were pindolol 0.015 mg/kg intravenously and 10 mg/day orally, atenolol 0.1 mg/kg intravenously, and 50 mg/day orally. Heart rate at rest was reduced by both drugs. The reduction caused by atenolol during oral treatment was significantly greater (p less than 0.01). Intravenously only pindolol reduced mean arterial pressure. During oral treatment atenolol reduced the mean arterial pressure nonsignificantly. Both drugs lowered heart rate during isometric exercise, atenolol being significantly more effective. During oral treatment atenolol blunted the heart-rate reaction to exercise. Mean arterial pressure during isometric exercise rose slightly with both drugs after intravenous administration. During oral treatment only atenolol reduced the mean arterial pressure significantly. Intravenous atenolol reduced cardiac contractility at rest, indicated by significant decreases in fractional shortening, ejection fraction, and the mean velocity of circumferential fiber shortening. In contrast, intravenous pindolol and oral therapy with either drug did not change contractility. Intravenous atenolol raised total peripheral resistance. The preejection period/left ventricular ejection time ratio decreased with intravenous pindolol, while atenolol increased it. In conclusion, atenolol had more negative inotropic and chronotropic effects, especially after acute intravenous administration. Only atenolol reduced cardiac output and increased peripheral resistance. After repeated oral administration, these effects were less apparent.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076384     DOI: 10.1007/BF01856563

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  35 in total

1.  Left ventricular volume measurement by echocardiography: fact or fiction?

Authors:  J W Linhart; G S Mintz; B L Segal; N Kawai; M N Kotler
Journal:  Am J Cardiol       Date:  1975-07       Impact factor: 2.778

2.  The demonstration of atenolol as a beta-adrenoceptor blocking drug in man.

Authors:  J D Harry
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

3.  Left ventricular function and regional myocardial blood flow after atenolol in normals and patients with coronary artery disease.

Authors:  P Lichtlen; I Amende; R Simon; H J Engel; H Hundeshagen
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

4.  Studies with LB 46, a new beta-receptor blocking drug.

Authors:  I Lubawski; J Wale
Journal:  Eur J Pharmacol       Date:  1969       Impact factor: 4.432

5.  Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.

Authors:  W Schiess; D Welzel; R Gugler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Recommendations for standardization of measurements from M-mode echocardiograms.

Authors:  J Roelandt; D G Gibson
Journal:  Eur Heart J       Date:  1980-10       Impact factor: 29.983

7.  Systolic time intervals: prognostic value and exercise responses.

Authors:  D H Spodick
Journal:  Adv Cardiol       Date:  1982

8.  Relative potency of intravenous prinodolol and propranolol in man.

Authors:  A G Arbab; D C Hicks; P Turner
Journal:  Br J Pharmacol       Date:  1971-08       Impact factor: 8.739

9.  Controlled study of atenolol in treatment of hypertension.

Authors:  L Hansson; H Aberg; B E Karlberg; A Westerlund
Journal:  Br Med J       Date:  1975-05-17

10.  Unreliability of M-mode left ventricular dimensions for calculating stroke volume and cardiac output in patients without heart disease.

Authors:  S Rasmussen; B C Corya; J F Phillips; M J Black
Journal:  Chest       Date:  1982-05       Impact factor: 9.410

View more
  1 in total

1.  Atenolol blunts blood pressure increase during dynamic resistance exercise in hypertensives.

Authors:  Ricardo S Gomides; Luiz A R Costa; Dinoélia R Souza; Andréia C C Queiroz; João R C Fernandes; Kátia C Ortega; Décio Mion Junior; Taís Tinucci; Cláudia L M Forjaz
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.